1.Kotloff KL, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bulletin of the World Health Organization 1999; 77: 651–666.
2.Wittenberg DF. Emerging and re-emerging diseases – epidemic enterohaemorrhagic infections 100 years after Shiga. South Africa Medical Journal 1999; 89: 750–752.
3.von Seidlein L, et al. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Medicine 2006; 3: 353.
4.CDC. Health status of displaced persons following Civil War – Burundi, December 1993–January 1994. Morbidity and Mortality Weekly Report 1994; 43: 701–703.
5.Rahaman MM, et al. An outbreak of dysentery caused by Shigella dysenteriae type 1 on a coral island in the Bay of Bengal. Journal of Infectious Diseases 1975; 132: 15–19.
6.Niyogi SK. Shigellosis. Journal of Microbiology 2005; 43: 133–143.
7.DuPont HL, et al. Inoculum size in shigellosis and implications for expected mode of transmission. Journal of Infectious Diseases 1989; 159: 1126–1128.
8.Levine OS, Levine MM. Houseflies (Musca domestica) as mechanical vectors of shigellosis. Review of Infectious Diseases 1991; 13: 688–696.
9.Anon. Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994? Goma Epidemiology Group. Lancet 1995; 345: 339–344.
10.CDC. Outbreaks of multidrug-resistant Shigella sonnei gastroenteritis associated with day care centers – Kansas, Kentucky, and Missouri 2005. Morbidity and Mortality Weekly Report 2006; 55: 1068–1071.
11.Mohle-Boetani JC, et al. Communitywide shigellosis: control of an outbreak and risk factors in child day-care centers. American Journal of Public Health 1995; 85: 812–816.
12.Bennish ML, Wojtyniak BJ. Mortality due to shigellosis: community and hospital data. Review of Infectious Diseases 1991; 13 (Suppl. 4): 245–251.
13.Koster F, et al. Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. New England Journal of Medicine 1978; 298: 927–933.
14.van den Broek JM, et al. Risk factors for mortality due to shigellosis: a case-control study among severely-malnourished children in Bangladesh. Journal of Health, Population and Nutrition 2005; 23: 259–265.
15.Chao HC, et al. Bacterial enteric infections in children: etiology, clinical manifestations and antimicrobial therapy. Expert Review of Anti-Infective Therapy 2006; 4: 629–638.
16.Finkelstein JA, et al. Antimicrobial use in defined populations of infants and young children. Archives of Pediatrics & Adolescent Medicine 2000; 154: 395–400.
17.Jain R, Danziger LH. The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview. Current Pharmaceutical Design 2004; 10: 3045–3053.
18.Sivapalasingam S, et al. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrobial Agents and Chemotherapy 2006; 50: 49–54.
19.Coster TS, et al. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602. Infection and Immunity 1999; 67: 3437–3443.
20.Jennison AV, Verma NK. Shigella flexneri infection: pathogenesis and vaccine development. FEMS Microbiology Reviews 2004; 28: 43–58.
21.Kotloff KL, et al. Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infection and Immunity 1996; 64: 4542–4548.
22.Phalipon A, Mulard LA, Sansonetti PJ. Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path? Microbes and Infection 2008; 10: 1057–1062.
23.Blum LS, Nahar N. Cultural and social context of dysentery: implications for the introduction of a new vaccine. Journal of Health, Population and Nutrition 2004; 22: 159–169.
24.Pack R, et al. Willingness to be vaccinated against shigella and other forms of dysentery: a comparison of three regions in Asia. Vaccine 2006; 24: 485–494.
25.Youlong G, et al. Perceptions of Shigella and of Shigella vaccine among rural Chinese: compatibility with Western models of behavioral change. Southeast Asian Journal of Tropical Medicine and Public Health 2004; 35: 97–108.
26.Jheeta M, Newell J. Childhood vaccination in Africa and Asia: the effects of parents' knowledge and attitudes. Bulletin of the World Health Organization 2008; 86: 419.
27.Esrey SA, Habicht JP. Epidemiologic evidence for health benefits from improved water and sanitation in developing countries. Epidemiologic Reviews 1986; 8: 117–128.
28.Ram PK, et al. Risk factors for typhoid fever in a slum in Dhaka, Bangladesh. Epidemiology and Infection 2007; 135: 458–465.
29.Chen X, et al. Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China. Vaccine 2006; 24: 561–571.
30.Clark DV, et al. Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels. American Journal of Tropical Medicine and Hygiene 2005; 72: 786–791.
31.Muniyandi M, et al. Socio-economic dimensions of tuberculosis control: review of studies over two decades from Tuberculosis Research Center. Journal of Communicable Diseases 2006; 38: 204–215.
32.Russell S. The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome. American Journal of Tropical Medicine and Hygiene 2004; 71: 147–155.
33.Anon. Expanded Programme on Immunization (EPI). The Social Science and Immunization Research Project. Weekly Epidemiological Record 1998; 73: 285–288.
34.Streefland P, Chowdhury AM, Ramos-Jimenez P. Patterns of vaccination acceptance. Social Science and Medicine 1999; 49: 1705–1716.
35.Liao SL, et al. Survey of the status of self-paid varicella vaccination among children one to six years of age in Taiwan. Journal of Microbiology, Immunology and Infection 2007; 40: 112–115.
36.Do GC, et al. Household demand for typhoid fever vaccines in Hue, Vietnam. Health Policy Plan 2006; 21: 241–255.
37.Jamil K, et al. The immunization programme in Bangladesh: impressive gains in coverage, but gaps remain. Health Policy Plan 1999; 14: 49–58.
38.Levin A. Charging for family planning and MCH commodities and services: mid-term evaluation, MCH-FP extension project (rural). International Centre for Diarrhoeal Disease Research, Bangladesh, ICDDR'B, 1997 (Working Paper No. 93.).
39.Forrest JM, Burgess MA, McIntyre PB. Factors influencing vaccination uptake. Workshop report. Current Australian research on the behavioural, social and demographic factors influencing immunisation, Royal Alexandra Hospital for Children, Sydney, March 1998. Communicable Disease Intelligence 2000; 24: 51–53.
40.Sauerborn R, et al. Willingness to pay for hypothetical malaria vaccines in rural Burkina Faso. Scandinavian Journal of Public Health 2005; 33: 146–150.
41.Kaljee LM, et al. Acceptability and accessibility of a Shigellosis vaccine in Nha Trang city of Viet Nam. Journal of Health, Population and Nutrition 2004; 22: 150–158.
42.Checkley W, et al. Effect of water and sanitation on childhood health in a poor Peruvian peri-urban community. Lancet 2004; 363: 112–118.
43.van Poppel F, van der Heijden C. The effects of water supply on infant and childhood mortality: a review of historical evidence. Health Transition Review 1997; 7: 113–148.
44.Anon. Water and sanitation: the neglected health MDG. Lancet 2006; 368: 1212.
45.Clasen T, et al. Household water treatment using sodium dichloroisocyanurate (NaDCC) tablets: a randomized, controlled trial to assess microbiological effectiveness in Bangladesh. American Journal of Tropical Medicine and Hygiene 2007; 76: 187–192.